米国の網膜アトラス（2023年）：MedOp Index 分析

当レポートでは、米国の網膜アトラスについて調査し、米国85都市圏における網膜治療の機会と主要な人口統計指標の地域分析を提供します。

サンプルビュー

目次

• 特定都市人口の人口統計情報
• 選択した都市圏のプロファイルと適用可能な網膜治療機会
• 網膜手術件数の最新推計値、都市圏別
• 網膜外科医の最新推計値、都市圏別
• 網膜IVTおよび硝子体手術を実施する米国の眼科診療所の包括的ディレクトリ

• 網膜疾患モデル
• 世界の網膜デバイスモデル
• 人口統計モデル
• アトラスモデルと独自のMedOp Index（TM）分析
• 眼科医への調査および世論調査
• 経済および人口統計データ

What's New

The "2023 United States Retina Atlas" is now delivered exclusively in an Excel format that allows users to quickly sort through key metrics for eight United States regions, all 50 states, and the top 85 metropolitan areas in retinal treatment opportunity.

SAMPLE VIEW

The "2023 United States Retina Atlas" provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. Market Scope's proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Retina Atlas offers strategic insights into the top potential markets in the US by providing:

• Demographic information of selected metropolitan populations

• Profiles of selected metropolitan areas and applicable retinal treatment opportunity

• Current estimates for retinal surgery volume by metropolitan area

• Current estimates for retina surgeons by metropolitan area

• Comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies

The "2023 United States Retina Atlas" has been prepared using a variety of primary and secondary sources, including:

• Market Scope retinal disease models

• Market Scope global retinal device models

• Market Scope demographics models

• Market Scope atlas model and proprietary MedOp Index™ Analysis

• Market Scope surveys and polls of ophthalmologists

• Published economic and demographic data: US Census Bureau, United Health Foundation, Centers for Disease Control and Prevention, Medicare reimbursement data, and CMS facility data

Author Profile:

Chelsea Jones, MBA

Chelseahas over 10 years of experience as an analyst in multiple medical verticals.

After receiving her MBA, Chelsea began her career at Cerner Corporation, the leading supplier of healthcare information technology solutions, where she performed many analytical roles in the Population Health organization. She also has experience in crafting and executing competitive intelligence strategy, product development, and market opportunity assessment.

Chelsea authors the global ophthalmic laser report, the global refractive report, the global cornea report, the ophthalmic deals book, the US cataract atlas,the US refractive atlas, the US glaucoma atlas, and the US dry eye atlas. She is also a contributor to Market Scope's Ophthalmic Market Perspectives monthly industry newsletter.